SG11202104408UA - Novel lactic acid bacteria and use thereof - Google Patents

Novel lactic acid bacteria and use thereof

Info

Publication number
SG11202104408UA
SG11202104408UA SG11202104408UA SG11202104408UA SG11202104408UA SG 11202104408U A SG11202104408U A SG 11202104408UA SG 11202104408U A SG11202104408U A SG 11202104408UA SG 11202104408U A SG11202104408U A SG 11202104408UA SG 11202104408U A SG11202104408U A SG 11202104408UA
Authority
SG
Singapore
Prior art keywords
lactic acid
acid bacteria
novel lactic
novel
bacteria
Prior art date
Application number
SG11202104408UA
Other languages
English (en)
Inventor
Dong-Hyun Kim
Myung Joo Han
Original Assignee
Univ Industry Cooperation Group Kyung Hee Univ
Navipharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Industry Cooperation Group Kyung Hee Univ, Navipharm Co Ltd filed Critical Univ Industry Cooperation Group Kyung Hee Univ
Publication of SG11202104408UA publication Critical patent/SG11202104408UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Neurosurgery (AREA)
SG11202104408UA 2017-11-02 2019-04-30 Novel lactic acid bacteria and use thereof SG11202104408UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20170145420 2017-11-02
KR1020180132834A KR102151666B1 (ko) 2017-11-02 2018-11-01 신규 유산균 및 이의 용도
PCT/KR2019/005239 WO2020091166A1 (ko) 2017-11-02 2019-04-30 신규 유산균 및 이의 용도

Publications (1)

Publication Number Publication Date
SG11202104408UA true SG11202104408UA (en) 2021-05-28

Family

ID=66332068

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202104408UA SG11202104408UA (en) 2017-11-02 2019-04-30 Novel lactic acid bacteria and use thereof

Country Status (10)

Country Link
US (3) US11554146B2 (de)
EP (1) EP3875576A4 (de)
JP (1) JP6964191B2 (de)
KR (2) KR102151666B1 (de)
CN (1) CN113302279B (de)
AU (2) AU2018358456B2 (de)
BR (1) BR112021008358A2 (de)
CA (1) CA3081210C (de)
SG (1) SG11202104408UA (de)
WO (2) WO2019088379A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108624520B (zh) * 2017-03-16 2022-01-25 景岳生物科技股份有限公司 促进骨质再生的植物乳杆菌菌株gmnl-662及其组合物
US11554146B2 (en) * 2017-11-02 2023-01-17 University-Industry Cooperation Group Of Kyung Hee University Lactic acid bacteria and use thereof
US20240058398A1 (en) * 2020-12-16 2024-02-22 Meiji Co., Ltd. Composition for improving inflammation of brain tissue
KR102533469B1 (ko) * 2021-01-05 2023-05-17 연세대학교 산학협력단 염증성 장 질환의 예방 또는 치료용 조성물
IL305830A (en) * 2021-03-12 2023-11-01 Marvelbiome Inc Methods and uses of microbiome compositions, components or metabolites for the treatment of eye disorders
KR102488062B1 (ko) * 2021-03-19 2023-01-12 서원대학교산학협력단 녹용 발효추출물을 포함하는 여성 갱년기 운동성 감소의 예방 또는 치료용 조성물
KR102445903B1 (ko) * 2021-07-06 2022-09-22 롯데제과 주식회사 혈당 상승 저해 및 스트레스 조절 효과가 우수한 열처리된 락토바실러스 플랜타럼 lrcc5314 균주 및 용도
KR20240115991A (ko) * 2023-01-19 2024-07-29 재단법인 대구경북첨단의료산업진흥재단 골 질환 예방 또는 치료를 위한 신규 유산균 및 이의 배양액

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102129934B1 (ko) 2013-04-03 2020-07-03 프로비 아베 골다공증의 치료 또는 예방에 사용되는 프로바이오틱 스트레인
ITMI20130794A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
KR101638984B1 (ko) 2013-05-29 2016-07-13 바이오제닉스코리아 주식회사 나노형 김치 유산균
KR101740583B1 (ko) 2014-02-17 2017-05-29 경희대학교 산학협력단 비만 억제 효능을 갖는 신규 유산균 및 이의 용도
KR101709246B1 (ko) * 2014-05-30 2017-02-22 일동후디스 주식회사 다시마 및 복합 유산균을 이용한 항비만용 신바이오틱스 조성물
KR101690738B1 (ko) * 2014-08-25 2016-12-29 고려대학교 산학협력단 발효 율피 추출물을 유효성분으로 포함하는 항당뇨 조성물
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
MX2018001851A (es) 2015-08-31 2018-05-17 Nestec Sa Metodos y composiciones que usan bifidobacterium longum para tratar o prevenir sintomas depresivos.
KR20170032815A (ko) 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
WO2017047968A1 (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 다양한 기능성을 가진 신규 유산균 및 이의 용도
KR101824147B1 (ko) 2015-11-10 2018-01-31 경남과학기술대학교 산학협력단 증진된 생리활성을 갖는 콩 발효조성물 및 이를 포함하는 갱년기 또는 폐경기 증상 개선용 건강기능성 식품
KR101750468B1 (ko) * 2016-03-04 2017-06-27 주식회사 메디오젠 락토바실러스 퍼멘툼 mg901 또는 락토바실러스 플란타룸 mg989를 포함하는 조성물
KR101784847B1 (ko) * 2016-05-10 2017-10-13 주식회사 하우동천 질염 예방 및 치료용 유산균 함유 조성물 및 이의 용도
KR20160085235A (ko) 2016-06-28 2016-07-15 바이오제닉스코리아 주식회사 면역증진 및 장내환경개선용 건강기능성 아이스크림
US11554146B2 (en) * 2017-11-02 2023-01-17 University-Industry Cooperation Group Of Kyung Hee University Lactic acid bacteria and use thereof
CN108085269B (zh) * 2017-11-23 2019-12-06 中国农业科学院麻类研究所 甲基营养型芽孢杆菌菌株ibfcbf-2及其应用

Also Published As

Publication number Publication date
KR102151666B1 (ko) 2020-09-04
US11554146B2 (en) 2023-01-17
CN113302279A (zh) 2021-08-24
AU2021269282B2 (en) 2023-08-17
US20230181656A1 (en) 2023-06-15
US12036253B2 (en) 2024-07-16
WO2019088379A1 (ko) 2019-05-09
KR20200104848A (ko) 2020-09-04
US20230181657A1 (en) 2023-06-15
JP2021501586A (ja) 2021-01-21
EP3875576A1 (de) 2021-09-08
CA3081210A1 (en) 2019-05-09
KR102173547B1 (ko) 2020-11-03
US20210260140A1 (en) 2021-08-26
KR20190050294A (ko) 2019-05-10
CA3081210C (en) 2023-04-11
BR112021008358A2 (pt) 2021-08-03
AU2021269282A1 (en) 2021-12-09
AU2018358456B2 (en) 2021-10-28
EP3875576A4 (de) 2022-03-02
WO2020091166A1 (ko) 2020-05-07
JP6964191B2 (ja) 2021-11-10
CN113302279B (zh) 2024-07-30
AU2018358456A1 (en) 2020-05-28

Similar Documents

Publication Publication Date Title
SG10201913050RA (en) Novel lactic acid bacteria and use thereof
EP3483259A4 (de) Neuartige milchsäurebakterien und verwendung davon
SG11201911984QA (en) Novel lactic acid bacteria and use thereof
SG11202104408UA (en) Novel lactic acid bacteria and use thereof
EP3715449C0 (de) Neuartige milchsäurebakterien und verwendung davon
PL2937424T3 (pl) Bakteria kwasu mlekowego, kompozycja ją zawierająca i ich zastosowanie
EP3722412A4 (de) Neuartige bifidobacterium-bakterien und zusammensetzung mit neuartigen bifidobacterium-bakterien
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
DK3172315T3 (da) Fagresistente mælkesyrebakterier
PL3265043T3 (pl) Urządzenie pomagające w przenoszeniu i ćwiczeniach pacjenta
EP3735456C0 (de) Neuartige milchsäurebakterien und deren anwendungen
GB201519088D0 (en) The use of bacteria formulations
EP3262183A4 (de) Bakterienidentifizierung und test zur empfindlichkeit gegenüber antimikrobiellen mitteln
PL3431580T3 (pl) Bakterie kwasu mlekowego do wytwarzania kiszonki i dodatek do wytwarzania kiszonki
IL283418A (en) Christenella family bacteria including Christenella minuta and uses thereof
EP3483281A4 (de) Extrazelluläres polysaccharid von milchsäurebakterien und verwendung davon
EP3568460A4 (de) Neuartige milchsäurebakterien und deren anwendungen
IL251885A0 (en) Noscapinoid-Producing Bacteria and Methods for Their Preparation and Use
PT3481182T (pt) Bactérias probióticas para peixes
HK1248756A1 (zh) 乳酸菌及其用於治療乳腺炎的用途
TWI559925B (en) Novel lactobacillus mali aps1 and use thereof
EP3722413A4 (de) Neuartige bifidobacterium-bakterien und zusammensetzung mit neuartigen bifidobacterium-bakterien
IL269546A (en) Lactic acid bacteria, methods and uses thereof
HK1243951A1 (zh) 抗微生物組合和其在治療微生物感染中的用途
SG11201702816QA (en) Lactic acid bacteria having purine uptake ability and use thereof